首页> 美国卫生研究院文献>other >Nanotechnology: A Valuable Strategy to Improve Bacteriocin Formulations
【2h】

Nanotechnology: A Valuable Strategy to Improve Bacteriocin Formulations

机译:纳米技术:改善细菌素配方的重要战略

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Bacteriocins are proteinaceous antibacterial compounds, produced by diverse bacteria, which have been successfully used as: (i) food biopreservative; (ii) anti-biofilm agents; and (iii) additives or alternatives to the currently existing antibiotics, to minimize the risk of emergence of resistant strains. However, there are several limitations that challenge the use of bacteriocins as biopreservatives/antibacterial agents. One of the most promising avenues to overcome these limitations is the use of nanoformulations. This review highlights the practical difficulties with using bacteriocins to control pathogenic microorganisms, and provides an overview on the role of nanotechnology in improving the antimicrobial activity and the physicochemical properties of these peptides.
机译:细菌素是由多种细菌产生的蛋白质类抗菌化合物,已成功用作:(i)食品生物防腐剂; (ii)抗生物膜剂; (iii)替代现有抗生素的添加剂或替代品,以最大程度地降低出现耐药菌株的风险。然而,存在一些限制挑战细菌素作为生物防腐剂/抗菌剂的使用。克服这些限制的最有前途的途径之一是使用纳米制剂。这篇综述突出了使用细菌素控制病原微生物的实际困难,并概述了纳米技术在改善这些肽的抗菌活性和理化特性方面的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号